Ocular blood flow alters with age

Article

There is a large variation in the blood flow to the macula across a 24-hour period in old, but not young, eyes, according to results published in the August issue of the Journal of Glaucoma.

There is a large variation in the blood flow to the macula across a 24-hour period in old, but not young, eyes, according to results published in the August issue of the Journal of Glaucoma.

Teruyo Kida, MD, PhD of the Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, US and colleagues monitored the blood flow to the optical nerve head and the macula in one group of subjects aged 50–80 years (n=15), and in a second group of subjects aged 20–25 years (n=15). The subjects spent 24 hours under observation, and blood pressure and intraocular pressure (IOP) were measured - after five minutes sitting upright - every two hours, to calculate ocular perfusion pressure. Blood volume, flow and velocity in the optic nerve head and macula were also monitored.

The team found that nocturnal IOP was significantly lower than diurnal IOP among the older subjects, although ocular perfusion pressure remained stable. Ocular blood flow increased from 6.8% during the day to 16.8% at night in this group. The second group (younger subjects) were found to have higher IOP and lower ocular perfusion pressure at night compared with during the day, although ocular blood flow did not vary during the study period. Nocturnal ocular perfusion pressure was higher in older subjects compared with younger subjects.

The team concluded that the changes in the blood flow to the optic nerve head and the macula, which were confined to the older subjects, were independent of changes in ocular perfusion pressure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.